A detailed history of Massachusetts Financial Services CO transactions in Incyte Corp stock. As of the latest transaction made, Massachusetts Financial Services CO holds 36,010 shares of INCY stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,010
Previous 38,436 6.31%
Holding current value
$2.09 Million
Previous $2.41 Million 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$56.55 - $66.59 $137,190 - $161,547
-2,426 Reduced 6.31%
36,010 $2.05 Million
Q4 2023

Feb 08, 2024

SELL
$52.16 - $64.19 $235,189 - $289,432
-4,509 Reduced 10.5%
38,436 $2.41 Million
Q3 2023

Nov 08, 2023

BUY
$57.77 - $65.93 $884,978 - $1.01 Million
15,319 Added 55.45%
42,945 $2.48 Million
Q2 2023

Aug 09, 2023

BUY
$60.95 - $75.51 $1.68 Million - $2.09 Million
27,626 New
27,626 $1.72 Million
Q2 2022

Aug 09, 2022

SELL
$66.18 - $83.18 $5.09 Million - $6.4 Million
-76,955 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$66.02 - $79.71 $3.26 Million - $3.94 Million
-49,420 Reduced 39.11%
76,955 $6.11 Million
Q4 2021

Feb 10, 2022

SELL
$63.34 - $74.11 $253,106 - $296,143
-3,996 Reduced 3.07%
126,375 $9.28 Million
Q3 2021

Nov 10, 2021

SELL
$68.67 - $84.02 $870,872 - $1.07 Million
-12,682 Reduced 8.87%
130,371 $8.97 Million
Q2 2021

Aug 13, 2021

SELL
$79.87 - $87.53 $451,584 - $494,894
-5,654 Reduced 3.8%
143,053 $12 Million
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $345,814 - $457,174
-4,549 Reduced 2.97%
148,707 $12.1 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $672,160 - $813,352
-8,325 Reduced 5.15%
153,256 $13.3 Million
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $1.07 Million - $1.38 Million
-12,611 Reduced 7.24%
161,581 $14.5 Million
Q2 2020

Aug 11, 2020

SELL
$74.18 - $108.93 $6.85 Million - $10.1 Million
-92,397 Reduced 34.66%
174,192 $18.1 Million
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $4.73 Million - $6.44 Million
-74,870 Reduced 21.93%
266,589 $19.5 Million
Q4 2019

Feb 13, 2020

SELL
$73.04 - $95.72 $9.97 Million - $13.1 Million
-136,525 Reduced 28.56%
341,459 $29.8 Million
Q3 2019

Nov 05, 2019

BUY
$72.82 - $86.52 $23.8 Million - $28.3 Million
327,456 Added 217.54%
477,984 $35.5 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $3.47 Million - $4.19 Million
47,186 Added 45.66%
150,528 $12.8 Million
Q1 2019

May 13, 2019

SELL
$63.56 - $88.17 $1.04 Million - $1.44 Million
-16,364 Reduced 13.67%
103,342 $8.89 Million
Q4 2018

Feb 08, 2019

SELL
$58.5 - $69.94 $2.51 Million - $3 Million
-42,958 Reduced 26.41%
119,706 $7.61 Million
Q3 2018

Oct 25, 2018

SELL
$61.75 - $74.23 $5.13 Million - $6.16 Million
-83,051 Reduced 33.8%
162,664 $11.2 Million
Q2 2018

Jul 30, 2018

SELL
$60.85 - $83.98 $12.9 Million - $17.9 Million
-212,588 Reduced 46.39%
245,715 $16.5 Million
Q1 2018

May 04, 2018

BUY
$83.06 - $100.98 $63,125 - $76,744
760 Added 0.17%
458,303 $38.2 Million
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $42.8 Million - $53.3 Million
457,543
457,543 $43.3 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.